Together, We Transform 60+: Alpro Group Advance Early Thyroid Detection for Ageing Malaysians
Nationwide initiative brings thyroid awareness, health education, targeted TSH screening and referral closer to the community, empowering older Malaysians to better understand their thyroid health.
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 19 October 2026 – Alpro Group today announced a launch on "Together, We Transform 60+", a community health initiative designed to help ageing Malaysians better understand their health risks, identify potential thyroid dysfunction earlier and receive guidance towards appropriate care. This programme is supported by Merck Sdn Bhd, formalised through a Memorandum of Understanding (MOU), focusing on increasing community awareness among older Malaysian adults aged 60 years and above, particularly those living with hypertension and cholesterol conditions. The initiative reflects a shared commitment to bringing preventive healthcare closer to the community, helping individuals recognised potentially overlooked thyroid symptoms and take informed action.
Thyroid hormones play an important role in regulating many functions of the body, including metabolism, energy levels, heart function, muscle function and cognitive wellbeing. However, when thyroid function becomes abnormal, the signs may not always be obvious.
Persistent fatigue, changes in memory or concentration, chronic constipation, muscle aches or unexplained weakness may be attributed to ageing or existing health conditions. While these symptoms do not necessarily indicate a thyroid disorder, persistent or unexplained symptoms may warrant further medical evaluation.
Unmanaged thyroid dysfunction can affect a person's overall health and quality of life and, depending on the condition, may contribute to complications affecting cardiovascular, metabolic, cognitive and musculoskeletal health. Identifying potential thyroid dysfunction earlier provides an opportunity for at-risk individuals to seek appropriate clinical assessment and management before the condition has a greater impact on their wellbeing.
TSH screening can play an important role in addressing this gap. TSH testing is widely used as an initial indicator of thyroid function and can help identify individuals whose results suggest that further thyroid assessment may be needed.
One of the challenges in thyroid health is not simply access to care but recognising who should be assessed in the first place. An older adult may continue living with subtle symptoms for months or even years without realising that these changes could warrant further investigation. By bringing thyroid awareness and targeted screening into community healthcare settings, the collaboration aims to reach individuals who may otherwise remain undetected.
As part of the initiative, Alpro is supporting screening initiatives at retail outlets to screen individuals with abnormal or borderline screening results to be guided to seek further clinical evaluation for confirmation and appropriate management, creating a structured pathway from awareness to screening and, where necessary, onwards to professional healthcare follow-up.
Through Alpro Group's community healthcare network, the initiative aims to make that first step more accessible. Individuals can learn about thyroid health, better understand potential warning signs and access initial screening closer to where they live. Importantly, the programme does not end with a screening result. Those who may require further assessment will be guided towards appropriate clinical follow-up.
Insights from the programme will be used to strengthen the screening and referral model, with the aim of progressively expanding thyroid health initiatives across selected Alpro healthcare touchpoints nationwide. By leveraging Alpro Group's community healthcare reach supported by Merck Sdn Bhd, both organisations aim to develop a practical and scalable approach that can benefit more Malaysians over time.
Dr. Cheng Duo-Ying, Deputy Medical Director of Alpro Clinic Group, said: "For many older adults, symptoms such as tiredness, constipation, reduced concentration or muscle weakness can easily be accepted as part of ageing. The concern is when people continue living with these symptoms without knowing that further assessment may be needed. Through Together, We Transform 60+, we want to make awareness and early screening more accessible within the community, and importantly, ensure that individuals identified as being at risk are guided towards the appropriate next step in their care."
Pixie Yee, Managing Director, Merck Malaysia and General Manager Healthcare, Merck MYSG, said: "Early detection can make a meaningful difference in thyroid health, but reaching individuals who may not recognise that they are at risk remains an important challenge. Awareness is an important first step in thyroid health, yet many individuals may not recognise symptoms that warrant further attention. Alpro Group's strong presence within Malaysian communities provides an important platform to increase public understanding of thyroid health. Through this collaboration, we hope to support community education efforts and encourage individuals to seek timely medical assessment when appropriate.
The programme reflects a shared belief that preventive healthcare should not begin only when a condition becomes serious. It should begin in the community by helping people understand their risks, recognise changes in their health and access appropriate assessment at the right time.
Hashtag: #AlproGroup
The issuer is solely responsible for the content of this announcement.
About Alpro Group
Founded in 2002, Alpro Group's ecosystem has grown to include Alpro Pharmacy, Apotek Alpro, Alpro スギ (Sugi) Pharmacy, Alpro Physio, Alpro Clinic, Alpro Baby, Alpro OptiSaver, Alpro Audiology, Alpro Health, and Alpro Foundation. Supported by a team of more than 1,000 healthcare professionals, including doctors, pharmacists, nutritionists, dietitians, physiotherapists, optometrist and many others, Alpro serves over 5 million families in Malaysia and Indonesia through its extensive network of 500 physical outlets.
Alpro Pharmacy is the first and only community pharmacy in the region to offer product liability insurance of MYR 1 million in Malaysia and IDR 3 billion in Indonesia, ensuring the supply of genuine medications and enhancing consumer trust.
With the vision of a healthy and vibrant world, Alpro Group aims to become the No. 1 prescription pharmacy chain in Southeast Asia.
Merck
Merck KGaA, Darmstadt, Germany, is a vibrant science and technology company with a rich history dating back to 1668. Today, the company brings together more than 350 years of pioneering spirit and a global presence across 66 countries to help shape a better future through science and technology.
In Malaysia, Merck Healthcare is focused on helping more people benefit from innovation and advancing better health outcomes. With patients at the centre of its work, the company collaborates with healthcare professionals, patient communities, and partners to support care across the stages of life.
Its portfolio spans oncology, neurology and immunology, fertility, thyroid disorders, cardiovascular disease, diabetes, and growth hormone. Guided by a commitment to care, pioneer and outperform, Merck works to create, improve and prolong life and to make a meaningful difference for patients, customers, communities, and the planet.
